NRC National Research Corporation - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$20,35
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$11,0152 haftanın en düşüğü
$23,6852 haftanın en yükseği
Piyasa Değeri (MRQ)
$451M
P/E (TTM)
0.4
Hisse Başına Kâr (TTM)
$49.75
Gelir (TTM)
$140M
rozetleriniz
52 Haftlık Aralık
$11–$24
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$26
P/E
0.4
ROE
42.0%
Net Kâr Marjı
4.2%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
NRC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$20.35
Piyasa Değeri (MRQ)
$451M
P/E (TTM)
0.4
Hisse Başına Kâr (TTM)
$49.75
Gelir (TTM)
$140M
ROE (TTM)
42.0%
D/E Borç/Özsermaye (MRQ)
14.4
52 Haftlık Aralık
$11–$24
NRC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
National Research Corporation - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026.
History
National Research Corporation was established in 1981 to provide performance measurement tools and insights for the healthcare industry.
In 1994, the Picker Institute was founded and began development of the Qualisys technology the following year. In 1998, National Research Corporation acquired Healthcare Research Systems, Inc., expanding its offerings in patient experience measurement.
In 2001, the company purchased the Picker Institute's healthcare survey business, enhancing its market presence in patient-centered research. Expansion continued in 2003 with the acquisition of Smaller World Communications, based in Canada.
The company entered the health risk assessment sector in 2005 through the acquisition of Geriatric Health Systems LLC. In 2006, it acquired TGI Group LLC, which led to the creation of The Governance Institute, a resource for healthcare governance education and research.
In 2009, National Research Corporation acquired My InnerView, a firm recognized for its long-term care quality and satisfaction surveys. This was followed in 2010 by the acquisition of OCS HomeCare, a provider of clinical and outcomes analytics for home health and hospice care.
In 2014, the company acquired Digital Assent, the first software platform to enable healthcare organizations to publish physician star ratings based on patient experience data.
In 2016, National Research Corporation rebranded as NRC Health, reflecting a broader commitment to human-centered care and consumer insights.
On February 11, 2020, NRC Health experienced a cyberattack that resulted in the temporary shutdown of its operations and raised concerns about the security of patient data maintained on behalf of its healthcare clients.
Awards
NRC Health is associated with several healthcare recognition programs, including the Consumer Choice Award, the AHCA/NCAL National Quality Award, and Excellence in Action. These programs acknowledge hospitals and long-term care providers based on performance metrics related to patient and resident satisfaction.
In 2010, the company was approved by the Centers for Medicare and Medicaid Services (CMS) as a vendor for the Home Health Consumer Assessment of Healthcare Providers and Systems (HHCAHPS) survey program.
In 2012 and 2013, Modern Healthcare identified NRC Health as the largest patient satisfaction measurement firm in the United States.
Products and services
Products and solutions provided by NRC Health follows the "Eight Dimensions of Patient-Centered Care" philosophy.
Under this strategy, the company provides:
Patient & Family Experience
Resident & Family Experience
Employee Engagement
Physician Engagement
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program
Market Insights
Healthcare Analytics
Clinical & Outcomes Analytics
Health Risk Assessments
Patient Outreach Programs
Integrated Solutions
The Institutes
CAHPS is a survey system, including HCAHPS, CGCAHPS, HHCAHPS, NHCAHPS, Pediatric HCAHPS, and ICHCAHPS.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealth Care
endüstriHealth Care
çalışanlar357
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$137M2016-12-31 → 2025-12-31
Hisse Başına Kâr$50.002019-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2024-12-31
Net kar marjı4.2%2016-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | NRC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 0.45Y ort. ≈21.4 | ≈21.4 | · | · | |
| F/S (TTM) | 3.25Y ort. ≈5.6 | ≈5.6 | 2.1 | Aşırı değerli | |
| F/D (MRQ) | 68.85Y ort. ≈14.4 | ≈14.4 | 3.1 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 20.85Y ort. ≈31.2 | ≈31.2 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 15.35Y ort. ≈21.2 | ≈21.2 | 12.8 | Aşırı değerli | |
| Fiyat / Maddi Defter Değeri (MRQ) | 101.3 | · | · | · | |
| PEG Ratio (PEG Oranı) | ≈0.0 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | NRC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 10.5%5Y ort. ≈29.1% | ≈29.1% | -0.07% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 6.7%5Y ort. ≈27.7% | ≈27.7% | 0.46% | Zayıf | |
| Net Kâr Marjı (TTM) | 4.2%5Y ort. ≈21.1% | ≈21.1% | -2.6% | Zayıf | |
| ROA (TTM) | 4.2%5Y ort. ≈22.9% | ≈22.9% | 0.70% | En üst düzey | |
| ROE (TTM) | 42.0%5Y ort. ≈55.8% | ≈55.8% | 10.9% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | NRC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 14.45Y ort. ≈0.6 | ≈0.6 | 0.0 | Yüksek borç | |
| Cari Oran (MRQ) | 0.75Y ort. ≈1.1 | ≈1.1 | 0.9 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 13.1 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | NRC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -4.0%5Y ort. ≈0.76% | ≈0.76% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -3.2%5Y ort. ≈-0.21% | ≈-0.21% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 0.61% | · | · | · | |
| EPS YoY (EPS YB) | 4707.7%5Y ort. ≈935.4% | ≈935.4% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -53.2%5Y ort. ≈-18.1% | ≈-18.1% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 240.2%5Y ort. ≈74.9% | ≈74.9% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 103.0% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -28.5%5Y ort. ≈-15.8% | ≈-15.8% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -20.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | NRC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$384.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Yıllıklaştırılmış Ödeme≈$0.64
Büyüme Serisi≈1
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Eyl 25, 2026 | $0,16 | USD | ≈3.3% |
| Haz 26, 2026 | $0,16 | USD | ≈2.9% |
| Mar 27, 2026 | $0,16 | USD | ≈3.3% |
| Ara 26, 2025 | $0,16 | USD | ≈2.8% |
| Eyl 26, 2025 | $0,12 | USD | ≈3.6% |
| Haz 27, 2025 | $0,12 | USD | ≈2.9% |
| Mar 28, 2025 | $0,12 | USD | ≈3.7% |
| Ara 27, 2024 | $0,12 | USD | ≈2.8% |
| Eyl 27, 2024 | $0,12 | USD | ≈2.1% |
| Haz 28, 2024 | $0,12 | USD | ≈6.4% |
| Mar 27, 2024 | $0,12 | USD | ≈3.8% |
| Ara 28, 2023 | $0,12 | USD | ≈3.8% |
| Eyl 28, 2023 | $0,12 | USD | ≈3.9% |
| Eyl 15, 2023 | $1,00 | USD | ≈3.5% |
| Haz 29, 2023 | $0,12 | USD | ≈1.4% |
| Mar 30, 2023 | $0,12 | USD | ≈1.7% |
| Ara 29, 2022 | $0,12 | USD | ≈2.3% |
| Eyl 29, 2022 | $0,24 | USD | ≈2.1% |
| Haz 29, 2022 | $0,24 | USD | ≈1.9% |
| Mar 30, 2022 | $0,24 | USD | ≈1.5% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
44.0%
Sonraki Rapor
Eki 26, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 27, 2026 | $0.31 | $0.14 | 119.2% |
| 31 Mart 2026 | $0.21 | — | — | |
| 31 Aralık 2025 | $0.16 | — | — | |
| 30 Eylül 2025 | $0.23 | — | — | |
| 30 Haziran 2019 | $0.29 | $0.26 | 10.4% | |
| 31 Mart 2019 | $0.32 | $0.31 | 2.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| SG&A Expense | $55M | $45M | $47M | $43M | $39M | $34M | $33M | $31M | $30M | $28M | $27M | $25M | |
| Operating Expenses | $115M | $108M | $109M | $105M | $98M | $91M | $85M | $84M | $83M | $78M | $76M | $71M | |
| Operating Income | $23M | $35M | $40M | $47M | $50M | $43M | $43M | $35M | $34M | $31M | $26M | $28M | |
| Interest Expense | · | $3M | $862.0K | $1M | $2M | $2M | $2M | $2M | $82.0K | $190.0K | $220.0K | $305.0K | |
| Interest Income | $111.0K | $125.0K | $820.0K | $168.0K | $14.0K | $18.0K | $37.0K | $62.0K | $96.0K | $47.0K | $60.0K | $83.0K | |
| Other Non-op | $-95.0K | $-34.0K | $-41.0K | $-118.0K | $4.0K | $585.0K | $-462.0K | $885.0K | $50.0K | $302.0K | $1M | $18.0K | |
| Pretax Income | $18M | $33M | $40M | $43M | $49M | $41M | $41M | $35M | $34M | $31M | $27M | $28M | |
| Income Tax | $6M | $8M | $9M | $11M | $11M | $4M | $8M | $5M | $11M | $11M | $10M | $10M | |
| Net Income | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| EPS (Basic) | $50.00 | $1.05 | $1.26 | $1.28 | $1.47 | $1.48 | $1.30 | · | · | · | · | · | |
| EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | · | · | · | · | · | |
| Shares (Basic) | 22,383,000 | 23,703,000 | 24,540,000 | 24,922,000 | 25,422,000 | 25,170,000 | 24,809,000 | · | · | · | · | · | |
| Shares (Diluted) | 22,396,000 | 23,743,000 | 24,673,000 | 25,052,000 | 25,640,000 | 25,696,000 | 25,653,000 | · | · | · | · | · | |
| EBITDA | · | $35M | $40M | $47M | $50M | · | $43M | $35M | $34M | $31M | $26M | $32M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $7M | $25M | $54M | $35M | $14M | $13M | $35M | $33M | $42M | $40M | |
| Receivables | $11M | $11M | $12M | $14M | $14M | $14M | $12M | $12M | $15M | $11M | $10M | $8M | |
| Prepaid Expense | $4M | $3M | $4M | $2M | $4M | $3M | $2M | $3M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $520.0K | $692.0K | $940.0K | $1M | $982.0K | $2M | $2M | $224.0K | $35.0K | $35.0K | $34.0K | $994.0K | |
| Current Assets | $20M | $20M | $24M | $44M | $74M | $54M | $29M | $28M | $52M | $47M | $55M | $53M | |
| PP&E (Net) | · | $38M | $28M | $17M | $12M | $12M | $14M | $14M | $12M | $12M | $11M | $12M | |
| PP&E (Gross) | · | $74M | $64M | $51M | $46M | $43M | $42M | $45M | $40M | $38M | $35M | $35M | |
| Accum. Depreciation | · | $35M | $36M | $34M | $33M | $31M | $29M | $31M | $28M | $26M | $23M | $23M | |
| Goodwill | $66M | $66M | $62M | $62M | $62M | $57M | $58M | $58M | $58M | $58M | $58M | $58M | |
| Intangibles | $2M | $3M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $4M | $5M | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $768.0K | $293.0K | $234.0K | |
| Total Assets | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $613.0K | $593.0K | $765.0K | $614.0K | $830.0K | |
| Accrued Liabilities | $3M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Short-term Debt | $4M | $5M | $7M | $4M | $4M | $4M | $4M | $4M | $1M | $3M | $2M | $2M | |
| Current Liabilities | $37M | $36M | $36M | $33M | $40M | $32M | $38M | $47M | $32M | $32M | $44M | $28M | |
| Capital Leases | $744.0K | $1M | $2M | · | · | · | · | $676.0K | $87.0K | $110.0K | $103.0K | $167.0K | |
| Deferred Tax | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $6M | $4M | $5M | $6M | $7M | |
| Other Non-current Liabilities | $3M | $4M | $4M | $2M | $3M | $4M | $2M | $1M | $935.0K | $777.0K | $575.0K | $541.0K | |
| Total Liabilities | $121M | $101M | $73M | $58M | $72M | $69M | $78M | $89M | $37M | $38M | $54M | $42M | |
| Long-term Debt | $79M | · | $37M | $22M | $27M | $31M | $34M | $38M | $1M | $4M | $6M | $8M | |
| Total Debt | · | $63M | $7M | $4M | $4M | · | $34M | $38M | $2M | $6M | $8M | $10M | |
| Common Stock | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $30.0K | $30.0K | $26.0K | · | · | · | |
| Retained Earnings | $-17M | $-17M | $-31M | $-25M | $-36M | $-61M | $-93M | $-106M | $78M | $72M | $65M | $74M | |
| Treasury Stock | $153M | $132M | $99M | $78M | $50M | $44M | $34M | $29M | $37M | $33M | $32M | $30M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-3M | $-3M | $-773.0K | |
| Stockholders' Equity | $14M | $31M | $49M | $72M | $85M | $64M | $33M | $19M | $90M | $83M | $74M | $88M | |
| Liabilities + Equity | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Shares Outstanding | 22,637,252 | 23,083,116 | 24,219,887 | 24,628,173 | 25,361,409 | 25,390,968 | 24,947,500 | 24,800,796 | 20,936,703 | · | · | · |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $6M | $6M | · | · | · | $6M | $5M | $5M | $4M | $4M | $4M | |
| Stock-based Comp | $3M | $284.0K | $935.0K | $1M | $623.0K | $680.0K | $1M | $2M | $2M | $2M | $1M | $742.0K | |
| Deferred Tax | $2M | $-664.0K | $-1M | $-2M | $-277.0K | $-134.0K | $1M | $1M | $-684.0K | $798.0K | $-1M | $107.0K | |
| Amort. of Intangibles | $389.0K | $264.0K | $140.0K | $180.0K | $320.0K | $318.0K | $374.0K | $662.0K | $610.0K | $654.0K | $995.0K | $876.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $26M | $35M | $38M | $36M | $46M | $41M | $41M | $40M | $28M | $27M | $22M | $26M | |
| CapEx | $11M | $15M | $16M | $10M | $6M | $4M | $5M | $6M | $5M | $4M | $3M | $2M | |
| Investing Cash Flow | $-11M | $-20M | $-16M | $-10M | $-9M | $-4M | $-5M | $-6M | $-6M | $-4M | $-1M | $-6M | |
| Stock Repurchased | $20M | $31M | $19M | $28M | $4M | · | · | · | · | · | $2M | · | |
| Net Stock Activity | · | $-31M | $-19M | $-28M | $-4M | · | · | · | · | · | $-2M | · | |
| Dividends Paid | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · | |
| Financing Cash Flow | $-16M | $-17M | $-41M | $-56M | $-18M | $-16M | $-36M | $-54M | $-21M | $-33M | $-17M | $-2M | |
| Net Change in Cash | $-94.0K | $-2M | $-18M | $-29M | $20M | $21M | $526.0K | $-22M | $2M | $-9M | $2M | $18M | |
| Taxes Paid | · | $8M | $9M | $12M | $11M | $5M | $7M | $3M | $13M | $10M | $9M | · | |
| Free Cash Flow | · | $19M | $22M | $26M | $41M | · | $36M | $34M | $24M | $23M | $19M | $24M | |
| Levered FCF | · | $17M | $22M | $26M | $40M | · | $35M | $33M | $23M | $23M | $19M | $24M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | |
| Net Margin | · | 17.3% | 20.8% | 21.0% | 25.3% | · | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | |
| Pretax Margin | · | 22.9% | 26.9% | 28.2% | 32.9% | · | 31.7% | 29.0% | 29.2% | 28.7% | 26.7% | 28.4% | |
| EBITDA Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 32.5% | |
| ROA | · | 19.4% | 24.5% | 22.1% | 25.8% | · | 29.6% | 25.5% | 18.5% | 16.5% | 13.6% | 15.1% | |
| ROE | · | 75.2% | 58.0% | 45.5% | 44.5% | · | 104.8% | 122.1% | 26.6% | 26.1% | 21.7% | 22.8% | |
| ROIC | · | 28.4% | 55.2% | 45.2% | 43.2% | · | 51.3% | 53.6% | 24.8% | 22.9% | 20.7% | 18.6% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.5 | 0.7 | 1.3 | 1.8 | · | 0.8 | 0.6 | 1.6 | 1.5 | 1.3 | 1.9 | |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 | · | 0.7 | 0.5 | 1.5 | 1.4 | 1.2 | 1.7 | |
| Debt / Equity | · | 2.0 | 0.1 | 0.1 | 0.1 | · | 1.0 | 2.0 | 0.0 | 0.1 | 0.1 | 0.1 | |
| LT Debt / Equity | · | 1.9 | · | · | · | · | 0.9 | 1.8 | · | 0.0 | 0.0 | 0.1 | |
| Interest Coverage | · | 13.6 | 46.5 | 38.5 | 30.2 | · | 20.6 | 23.3 | 417.3 | 164.2 | 120.2 | 92.8 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.1 | 1.0 | · | 1.2 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | |
| Receivables Turnover | · | 12.2 | 11.1 | 10.8 | 10.7 | · | 10.9 | 9.0 | 9.7 | 10.6 | 11.4 | 10.3 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.36 | $2.02 | $2.92 | $3.36 | · | $1.32 | $0.77 | · | · | · | · | |
| Revenue / Share | · | $6.03 | $6.02 | $6.05 | $5.77 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $1.46 | $1.54 | $1.45 | $1.81 | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.18 | $0.27 | $1.02 | $2.14 | · | $0.54 | $0.52 | · | · | · | · | |
| Dividend / Share | $0.52 | $0.48 | $1.48 | $0.84 | $0.48 | $0.21 | $0.78 | · | · | · | · | · | |
| EPS (TTM) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | $2.28 | $2.28 | $2.28 | $2.28 | $2.28 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.0% | -3.7% | -2.0% | 2.4% | 11.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -3.2% | -1.1% | 3.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.61% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4707.7% | -16.8% | -1.6% | -13.0% | 0.69% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 240.2% | -10.7% | -4.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -53.2% | -20.0% | -2.6% | -15.1% | 0.55% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -28.5% | -12.9% | -6.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -20.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 0.86% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| Net Income TTM | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| Market Cap | · | $407M | $958M | $919M | $1.05B | · | $1.65B | $946M | · | · | · | · | |
| Enterprise Value | · | $466M | $959M | $898M | $1.00B | · | $1.67B | $971M | · | · | · | · | |
| P/E | 0.4 | 17.0 | 31.6 | 29.4 | 28.4 | 29.5 | 52.3 | 16.7 | 16.4 | 8.3 | 7.0 | 6.1 | |
| P/S | · | 2.8 | 6.4 | 6.1 | 7.1 | · | 12.9 | 7.9 | · | · | · | · | |
| P/B | · | 13.0 | 19.6 | 12.8 | 12.3 | · | 50.0 | 49.6 | · | · | · | · | |
| P / Tangible Book | · | · | · | 104.3 | 48.0 | 192.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | 11.8 | 25.1 | 25.3 | 22.7 | · | 40.2 | 23.7 | · | · | · | · | |
| P / FCF | · | 21.2 | 42.9 | 34.8 | 25.8 | · | 45.4 | 27.9 | · | · | · | · | |
| EV / EBITDA | · | 13.2 | 23.9 | 19.3 | 20.0 | · | 38.7 | 27.5 | · | · | · | · | |
| EV / FCF | · | 24.3 | 42.9 | 34.0 | 24.6 | · | 45.9 | 28.7 | · | · | · | · | |
| EV / Revenue | · | 3.3 | 6.5 | 5.9 | 6.8 | · | 13.0 | 8.1 | · | · | · | · | |
| Dividend Yield | · | 2.8% | 3.8% | 2.3% | 0.87% | · | 1.9% | 1.8% | · | · | · | · | |
| Earnings Yield | 266.4% | 5.9% | 3.2% | 3.4% | 3.5% | 3.4% | 1.9% | 6.0% | 6.1% | 12.0% | 14.2% | 16.3% | |
| Payout Ratio | · | 46.2% | 117.4% | 65.9% | 24.4% | · | 96.6% | 56.1% | 73.5% | 139.2% | 57.1% | · | |
| Annual Payout | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35M | $35M | $35M | $35M | $34M | $34M | $37M | $36M | $35M | $35M | $38M | $38M | $36M | $36M | $38M | $38M | |
| SG&A Expense | $23M | $13M | $14M | $12M | $18M | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $12M | $11M | $11M | |
| Operating Expenses | $39M | $29M | $31M | $27M | $32M | $25M | $27M | $28M | $26M | $27M | $26M | $28M | $27M | $27M | $26M | $27M | |
| Operating Income | $-3M | $6M | $5M | $8M | $2M | $9M | $10M | $8M | $9M | $9M | $12M | $10M | $9M | $9M | $12M | $11M | |
| Interest Expense | · | · | · | $1M | $1M | $899.0K | · | $706.0K | $555.0K | $605.0K | · | $160.0K | $192.0K | $241.0K | $286.0K | $288.0K | |
| Interest Income | $20.0K | $35.0K | $30.0K | $41.0K | $21.0K | $19.0K | $22.0K | $34.0K | $25.0K | $44.0K | $41.0K | $256.0K | $273.0K | $250.0K | $134.0K | $15.0K | |
| Other Non-op | $2.0K | $30.0K | $-61.0K | $-45.0K | $4.0K | $7.0K | $-6.0K | $-12.0K | $-11.0K | $-5.0K | $-13.0K | $-12.0K | $-2.0K | $-14.0K | $-49.0K | $11.0K | |
| Pretax Income | $-5M | $4M | $3M | $6M | $581.0K | $8M | $9M | $7M | $8M | $8M | $11M | $10M | $9M | $9M | $9M | $11M | |
| Income Tax | $-1M | $1M | $1M | $2M | $687.0K | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Net Income | $-3M | $3M | $2M | $4M | $-106.0K | $6M | $7M | $6M | $6M | $6M | $9M | $8M | $7M | $7M | $7M | $8M | |
| EPS (Basic) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.28 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.30 | $0.28 | $0.27 | $0.34 | |
| EPS (Diluted) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.27 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.29 | $0.28 | $0.27 | $0.33 | |
| Shares (Basic) | 22,009,000 | 21,799,000 | · | 22,130,000 | 22,658,000 | 22,972,000 | · | 23,721,000 | 23,871,000 | 23,868,000 | · | 24,560,000 | 24,578,000 | 24,585,000 | · | 24,716,000 | |
| Shares (Diluted) | 22,009,000 | 21,911,000 | · | 22,130,000 | 22,658,000 | 22,974,000 | · | 23,745,000 | 23,915,000 | 23,963,000 | · | 24,695,000 | 24,716,000 | 24,738,000 | · | 24,847,000 | |
| EBITDA | $-3M | $6M | · | $8M | $2M | $9M | · | $8M | $9M | $9M | · | $10M | $9M | $9M | · | $11M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $4M | $2M | $5M | $3M | $4M | $3M | $485.0K | $2M | · | $4M | $22M | $24M | · | $28M | |
| Receivables | $9M | $11M | $11M | $13M | $12M | $11M | $11M | $11M | $10M | $11M | · | $14M | $12M | $14M | · | $15M | |
| Prepaid Expense | $5M | $6M | $4M | $4M | $5M | $6M | $3M | $5M | $5M | $6M | · | $6M | $6M | $6M | · | $4M | |
| Other Current Assets | $431.0K | $461.0K | $520.0K | $973.0K | $2M | $588.0K | $692.0K | $664.0K | $1M | $777.0K | · | $369.0K | $834.0K | $1M | · | $1M | |
| Current Assets | $23M | $20M | $20M | $20M | $25M | $20M | $20M | $21M | $17M | $20M | · | $25M | $41M | $45M | · | $49M | |
| PP&E (Net) | · | · | · | $41M | $42M | $40M | · | $36M | $34M | $32M | · | $26M | $23M | $19M | · | $16M | |
| PP&E (Gross) | · | · | · | $82M | $81M | $77M | · | $76M | $72M | $69M | · | $63M | $59M | $54M | · | $52M | |
| Accum. Depreciation | · | · | · | $41M | $38M | $37M | · | $40M | $39M | $37M | · | $37M | $36M | $35M | · | $36M | |
| Goodwill | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $62M | $62M | $62M | $62M | $62M | $62M | · | $62M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $3M | $4M | $6M | $2M | $3M | · | $4M | $5M | $4M | · | $3M | |
| Total Assets | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $3M | $1M | $2M | · | $1M | $2M | $1M | · | $1M | |
| Accrued Liabilities | $4M | $3M | $3M | $4M | $6M | $5M | $5M | $6M | $5M | $6M | · | $5M | $4M | $4M | · | $5M | |
| Short-term Debt | $4M | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $8M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Liabilities | $35M | $38M | $37M | $39M | $36M | $38M | $36M | $44M | $46M | $49M | · | $41M | $34M | $36M | · | $41M | |
| Capital Leases | · | · | $744.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $6M | $6M | $6M | $3M | $4M | $5M | $4M | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | · | $3M | $2M | $2M | · | $2M | |
| Total Liabilities | $130M | $121M | $121M | $121M | $120M | $106M | $101M | $97M | $79M | $84M | · | $62M | $56M | $60M | · | $67M | |
| Long-term Debt | $90M | · | · | · | · | · | · | $49M | $33M | $35M | · | $19M | $20M | $21M | · | $23M | |
| Total Debt | $94M | $78M | · | $80M | $81M | $62M | · | $49M | $33M | $35M | · | $5M | $5M | $5M | · | $4M | |
| Common Stock | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | · | $31.0K | $31.0K | $31.0K | · | $31.0K | |
| Retained Earnings | $-25M | $-18M | $-17M | $-15M | $-17M | $-14M | $-17M | $-21M | $-24M | $-27M | · | $-36M | $-17M | $-21M | · | $-29M | |
| Treasury Stock | $162M | $154M | $153M | $152M | $143M | $137M | $132M | $125M | $116M | $116M | · | $82M | $82M | $80M | · | $76M | |
| Stockholders' Equity | $7M | $13M | $14M | $14M | $21M | $30M | $31M | $35M | $40M | $37M | $49M | $58M | $78M | $75M | $72M | $68M | |
| Liabilities + Equity | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Shares Outstanding | 22,139,315 | 22,536,696 | 22,637,252 | 22,657,421 | 23,103,685 | 22,785,421 | 23,083,116 | 23,476,040 | 23,871,257 | 23,877,315 | · | 24,562,068 | 24,567,092 | 24,599,815 | · | 24,691,246 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | · | $1M | |
| Stock-based Comp | $7M | $2M | $2M | $925.0K | $307.0K | $171.0K | $188.0K | $189.0K | $-57.0K | $-36.0K | $258.0K | $68.0K | $305.0K | $304.0K | $290.0K | $291.0K | |
| Deferred Tax | $0 | $-36.0K | $3M | $-48.0K | $-2M | $2M | $-546.0K | $18.0K | $110.0K | $-246.0K | $-400.0K | $29.0K | $-373.0K | $-377.0K | $36.0K | $-486.0K | |
| Operating Cash Flow | $1M | $7M | $7M | $14M | $-1M | $7M | $6M | $9M | $7M | $12M | $12M | $10M | $9M | $8M | $8M | $10M | |
| CapEx | $1M | $2M | $1M | $4M | $3M | $3M | $4M | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $2M | $4M | |
| Investing Cash Flow | $-1M | $-2M | $-1M | $-4M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-4M | $-4M | $-4M | $-3M | $-2M | $-4M | |
| Stock Repurchased | $8M | $2M | $1.0K | $9M | $6M | $5M | $7M | $9M | $0 | $15M | $15M | $309.0K | $2M | $2M | $2M | $3M | |
| Net Stock Activity | · | $-2M | · | · | · | $-5M | · | · | · | $-15M | · | · | · | $-2M | · | · | |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $28M | $3M | $3M | $6M | $6M | |
| Financing Cash Flow | $718.0K | $-7M | $-4M | $-13M | $7M | $-5M | $-1M | $-17.0K | $-3M | $-13M | $-5M | $-24M | $-6M | $-6M | $-10M | $-10M | |
| Net Change in Cash | $780.0K | $-2M | $2M | $-3M | $3M | $-2M | $772.0K | $3M | $-1M | $-5M | $3M | $-19M | $-1M | $-1M | $-3M | $-5M | |
| Taxes Paid | · | · | · | $373.0K | $3M | $80.0K | $2M | $2M | $4M | $78.0K | $2M | $2M | $4M | $27.0K | $3M | $3M | |
| Free Cash Flow | · | $5M | · | · | · | $4M | · | · | · | $8M | · | · | · | $5M | · | · | |
| Levered FCF | · | · | · | · | · | $3M | · | · | · | $7M | · | · | · | $4M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| Net Margin | -9.3% | 9.3% | · | 11.9% | -0.31% | 17.2% | · | 15.9% | 17.6% | 18.0% | · | 20.8% | 20.1% | 19.1% | · | 22.0% | |
| Pretax Margin | -12.8% | 12.6% | · | 18.1% | 1.7% | 23.0% | · | 20.4% | 23.8% | 23.2% | · | 26.5% | 26.1% | 24.7% | · | 28.8% | |
| EBITDA Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| ROA | -2.4% | 2.4% | · | 3.1% | -0.08% | 4.5% | · | 4.5% | 4.9% | 5.0% | · | 6.2% | 5.4% | 4.9% | · | 5.7% | |
| ROE | -23.5% | 14.9% | · | 16.9% | -0.34% | 17.4% | · | 12.3% | 10.5% | 11.4% | · | 12.5% | 9.9% | 8.9% | · | 11.0% | |
| ROIC | -2.3% | 4.5% | · | 5.4% | -0.28% | 7.0% | · | 7.5% | 9.0% | 9.4% | · | 12.5% | 8.8% | 8.8% | · | 11.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | · | 0.5 | 0.7 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 1.2 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 1.0 | 1.1 | · | 1.1 | |
| Debt / Equity | 14.4 | 5.8 | · | 5.6 | 3.8 | 2.1 | · | 1.4 | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 13.1 | 5.5 | · | 5.3 | 3.6 | 2.0 | · | 1.3 | 0.6 | 0.7 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 5.3 | 1.5 | 9.6 | · | · | · | 14.5 | · | 62.2 | 48.8 | 37.4 | · | 38.6 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 3.3 | 3.1 | · | 2.9 | 3.0 | 3.0 | · | 2.8 | 3.2 | 2.8 | · | 2.5 | 2.9 | 2.4 | · | 2.4 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.30 | $0.60 | · | $0.63 | $0.92 | $1.30 | · | $1.47 | $1.68 | $1.55 | · | $2.36 | $3.16 | $3.04 | · | $2.74 | |
| Revenue / Share | $1.61 | $1.59 | · | $1.56 | $1.50 | $1.46 | · | $1.51 | $1.46 | $1.47 | · | $1.54 | $1.46 | $1.47 | · | $1.52 | |
| Cash Flow / Share | · | $0.33 | · | · | · | $0.29 | · | · | · | $0.50 | · | · | · | $0.31 | · | · | |
| Cash / Share | $0.15 | $0.11 | · | $0.10 | $0.23 | $0.11 | · | $0.15 | $0.02 | $0.07 | · | $0.16 | $0.92 | $0.96 | · | $1.15 | |
| Dividend / Share | $0.16 | $0.16 | $0.16 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $1.12 | $0.12 | $0.12 | $0.12 | $0.24 | |
| EPS (TTM) | $49.75 | $49.89 | · | $0.69 | $0.75 | $1.02 | · | $1.13 | $1.21 | $1.24 | · | $1.16 | $1.17 | $1.21 | · | $1.37 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $140M | $139M | · | $139M | $140M | $141M | · | $144M | $146M | $147M | · | $149M | $148M | $150M | · | $152M | |
| Net Income TTM | $6M | $9M | · | $16M | $18M | $24M | · | $27M | $29M | $30M | · | $29M | $29M | $30M | · | $35M | |
| Market Cap | $478M | $383M | · | $290M | $388M | $292M | · | $537M | $548M | $946M | · | $1.09B | $1.07B | $1.07B | · | $983M | |
| Enterprise Value | $568M | $458M | · | $367M | $464M | $351M | · | $582M | $581M | $979M | · | $1.09B | $1.05B | $1.05B | · | $959M | |
| P/E | 0.4 | 0.3 | · | 18.5 | 22.4 | 12.5 | · | 20.2 | 19.0 | 31.9 | · | 38.2 | 37.2 | 36.0 | · | 29.1 | |
| P/S | 3.4 | 2.8 | · | 2.1 | 2.8 | 2.1 | · | 3.7 | 3.7 | 6.4 | · | 7.3 | 7.2 | 7.2 | · | 6.5 | |
| P/B | 72.9 | 28.4 | · | 20.2 | 18.2 | 9.8 | · | 15.5 | 13.6 | 25.6 | · | 18.8 | 13.7 | 14.3 | · | 14.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 73.2 | 93.3 | · | 218.3 | |
| P / Cash Flow | · | 53.3 | · | · | · | 43.9 | · | · | · | 78.6 | · | · | · | 138.1 | · | · | |
| EV / Revenue | 4.1 | 3.3 | · | 2.6 | 3.3 | 2.5 | · | 4.0 | 4.0 | 6.6 | · | 7.3 | 7.1 | 7.0 | · | 6.3 | |
| Dividend Yield | 2.7% | 3.1% | · | 3.8% | 2.9% | 3.9% | · | 2.2% | 6.6% | 3.8% | · | 3.6% | 1.7% | 1.9% | · | 1.8% | |
| Earnings Yield | 230.6% | 293.8% | · | 5.4% | 4.5% | 8.0% | · | 4.9% | 5.3% | 3.1% | · | 2.6% | 2.7% | 2.8% | · | 3.4% | |
| Payout Ratio | · | 112.5% | · | · | · | 47.9% | · | · | · | 45.7% | · | · | · | 42.4% | · | · | |
| Annual Payout | $13M | $12M | · | $11M | $11M | $11M | · | $12M | $36M | $36M | · | $39M | $18M | $21M | · | $18M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $137M | $143M | $149M | $152M | $148M |
| Faaliyet Kâr Marjı % | · | 24.6% | 27.0% | 30.7% | 34.0% |
| Net Gelir | $12M | $25M | $31M | $32M | $37M |
| Seyreltilmiş Hisse Başı Kâr | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | 2.0 | 0.1 | 0.1 | 0.1 |
| Cari Oran | · | 0.5 | 0.7 | 1.3 | 1.8 |
| Cari Oran | · | 0.4 | 0.5 | 1.2 | 1.7 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | $19M | $22M | $26M | $41M |
Kurumsal Sahipler (13F) 133 dosya · $237.0M toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
133
Tutulan Değer
$237.0M
Yeni pozisyonlar
18
Çıkan pozisyonlar
11
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 18 (-1 önceki Ç'ye göre) | 11 (+1 önceki Ç'ye göre) | 43 (+14 önceki Ç'ye göre) | 39 (-15 önceki Ç'ye göre) | -77K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $43.797.714 | 2.030.492 | 18,48% | Hisse senetleri |
| BlackRock, Inc. | $22.893.428 | 1.061.355 | 9,66% | Hisse senetleri |
| MORGAN STANLEY | $18.534.465 | 859.269 | 7,82% | Hisse senetleri |
| VANGUARD GROUP INC | $15.604.984 | 831.379 | 6,58% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.377.570 | 666.554 | 6,07% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $10.595.956 | 491.228 | 4,47% | Hisse senetleri |
| Willis Investment Counsel | $9.378.312 | 434.785 | 3,96% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $9.062.880 | 420.056 | 3,82% | Hisse senetleri |
| FARMERS & MERCHANTS INVESTMENTS INC | $7.132.099 | 330.649 | 3,01% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $7.018.533 | 325.384 | 2,96% | Hisse senetleri |
| STATE STREET CORP | $6.483.381 | 298.384 | 2,74% | Hisse senetleri |
| HEARTLAND ADVISORS INC | $6.471.000 | 300.000 | 2,73% | Hisse senetleri |
| Bank of New York Mellon Corp | $5.440.710 | 252.235 | 2,30% | Hisse senetleri |
| NORTHERN TRUST CORP | $5.138.900 | 238.243 | 2,17% | Hisse senetleri |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $4.053.434 | 187.920 | 1,71% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $3.874.460 | 179.623 | 1,63% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $2.635.976 | 122.206 | 1,11% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.444.140 | 113.312 | 1,03% | Hisse senetleri |
| Northwest & Ethical Investments L.P. | $2.208.121 | 102.370 | 0,93% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.096.604 | 97.200 | 0,88% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $2.087.458 | 96.776 | 0,88% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.884.679 | 87.375 | 0,80% | Hisse senetleri |
| FIFTH THIRD BANCORP | $1.841.475 | 85.372 | 0,78% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $1.789.145 | 82.946 | 0,75% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.762.808 | 81.725 | 0,74% | Hisse senetleri |
| COMERICA BANK | $1.687.723 | 89.916 | 0,71% | Hisse senetleri |
| Linden Thomas Advisory Services, LLC | $1.679.311 | 77.854 | 0,71% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.675.644 | 77.684 | 0,71% | Hisse senetleri |
| Quantinno Capital Management LP | $1.577.892 | 73.152 | 0,67% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.382.529 | 64.095 | 0,58% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.357.573 | 62.938 | 0,57% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $1.354.184 | 62.781 | 0,57% | Hisse senetleri |
| SEI INVESTMENTS CO | $1.027.834 | 47.651 | 0,43% | Hisse senetleri |
| ALPS ADVISORS INC | $1.015.365 | 47.073 | 0,43% | Hisse senetleri |
| Williams Jones Wealth Management, LLC. | $901.626 | 41.800 | 0,38% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $831.847 | 38.565 | 0,35% | Hisse senetleri |
| Squarepoint Ops LLC | $798.112 | 37.001 | 0,34% | Hisse senetleri |
| US BANCORP \DE\ | $715.175 | 33.156 | 0,30% | Hisse senetleri |
| Nuveen, LLC | $653.959 | 30.318 | 0,28% | Hisse senetleri |
| HSBC HOLDINGS PLC | $634.793 | 29.539 | 0,27% | Hisse senetleri |
| Daiwa Securities Group Inc. | $629.218 | 29.171 | 0,27% | Hisse senetleri |
| Creative Planning | $624.487 | 28.952 | 0,26% | Hisse senetleri |
| MARSHALL WACE, LLP | $502.193 | 23.282 | 0,21% | Hisse senetleri |
| Empirical Finance, LLC | $431.400 | 20.000 | 0,18% | Hisse senetleri |
| Invesco Ltd. | $429.847 | 19.928 | 0,18% | Hisse senetleri |
| Cove Street Capital, LLC | $417.063 | 32.634 | 0,18% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $389.338 | 18.050 | 0,16% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $366.928 | 17.007 | 0,15% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $351.591 | 16.300 | 0,15% | Satım opsiyonu |
| ALLIANCEBERNSTEIN L.P. | $321.007 | 18.905 | 0,14% | Hisse senetleri |
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Common Property Trust, Common Property Trust LLC, Amandla, LLC, Beans Patrick E., Hays Michael D. ×3 başvurular | 12 Haziran 2026 | 45,70% | Değişiklik | · | SEC |
| Thomas Richardson, as the Trustee of Common Property Trust and as Manager of Common Property Trust LLC, Common Property Trust, Common Property Trust LLC ( ×2 başvurular | 05 Mart 2024 | · | İlk başvuru | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the Amandla MK Trust, Amandla MK Trust ×9 başvurular | 04 Ocak 2024 | · | İlk başvuru | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the K/I/E Trust Under Agreement 10/24/18, K/I/E Trust Under Agreement 10/24/18 | 15 Mart 2021 | · | İlk başvuru | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009), K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009) | 25 Nisan 2018 | · | İlk başvuru | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009, Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 | 14 Haziran 2013 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 27 içeriden öğrenenler · 13 yöneticiler · 11 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Trent S Green | Chief Executive Officer | 01 Haziran 2025 A | 500.000 | 0 | 0 | $0 |
| Shane R Harrison | EVP & Chief Financial Officer | 17 Şubat 2026 P | 8.000 | 1 | 0 | $98.160 |
| Kevin R Karas | SVP Finance, CFO, Treas & Secy | 28 Şubat 2023 S | 5.384 | 0 | 0 | $0 |
| Steven D. Jackson | President | 01 Ekim 2020 F | 55.567 | 0 | 0 | $0 |
| Susan L Henricks | President and COO | 07 Ocak 2014 A | 7.823 | 0 | 0 | $0 |
| Joseph W Carmichael | President | 09 Mayıs 2008 F | 41.872 | 0 | 0 | $0 |
| Helen Hrdy | EVP & Chief Operating Officer | 15 Aralık 2025 M | 140.518 | 0 | 0 | $0 |
| Jona S Raasch | COO, NRC Health | 03 Nisan 2023 S | 1.688 | 0 | 0 | $0 |
| Jason Russell Rau | Executive Vice President | 12 Mart 2026 A | 60.000 | 0 | 0 | $0 |
| David Burik | EVP, Strategic Insights | 05 Ocak 2026 A | 100.000 | 0 | 0 | $0 |
| Hays Michael D. | Chairman | 05 Ocak 2026 M | 20.154 | 0 | 0 | $0 |
| Jordan Nicole Freeman | Chief Accounting Officer | 31 Temmuz 2025 P | 771 | 0 | 0 | $0 |
| Andrew Monnich | Chief Corp. Development Off. | 07 Nisan 2025 A | 100.000 | 0 | 0 | $0 |
| Parul Bhandari | Yönetim kurulu üyesi | 23 Haziran 2026 A | 7.697 | 0 | 0 | $0 |
| Penny Ann Wheeler | Yönetim kurulu üyesi | 23 Haziran 2026 A | 7.697 | 0 | 0 | $0 |
| Stephen H Lockhart | Yönetim kurulu üyesi | 23 Haziran 2026 A | 7.697 | 0 | 0 | $0 |
| Donald M Berwick | Yönetim kurulu üyesi | 23 Haziran 2026 A | 7.697 | 0 | 0 | $0 |
| John N Nunnelly | Yönetim kurulu üyesi | 23 Haziran 2026 A | 40.363 | 0 | 0 | $0 |
| Joann M Martin | Yönetim kurulu üyesi | 29 Haziran 2021 A | 138.955 | 0 | 0 | $0 |
| Barbara Mowry | Yönetim kurulu üyesi | 15 Mayıs 2020 M | 42.902 | 0 | 0 | $0 |
| Gail L Warden | Yönetim kurulu üyesi | 09 Mayıs 2017 A | 10.263 | 0 | 0 | $0 |
| Paul C Schorr III | Yönetim kurulu üyesi | 28 Ekim 2013 G | 34.802 | 0 | 0 | $0 |
| Beans Patrick E. | 10% sahip | 12 Mayıs 2025 P | 35.003 | 0 | 0 | $0 |
| Common Property Trust | 10% sahip | 31 Aralık 2024 G | 4.755.317 | 0 | 0 | $0 |
| Amandla MK Trust | 10% sahip | 31 Aralık 2024 G | 0 | 0 | 0 | $0 |
| Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 | 10% sahip | 11 Mart 2021 S | 0 | 0 | 0 | $0 |
| Karen S Hays | 10% sahip | 12 Şubat 2010 G | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 21 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0,38% | 12.032 NS | 31 Temmuz 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 40.256 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,02% | 111.072 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 13.039 SH | 02 Ekim 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 68.097 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.633 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 301.953 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 62.228 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 5.634 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 560 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2.149 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.985 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 17.485 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.118 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 23.452 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 3.867 SH | 03 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 2.478 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 151.126 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 498.279 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 995 SH | 19 Ağustos 2026 | Günlük |
| SMLF · iShares Trust | · | 66.767 SH | 11 Eylül 2026 | Günlük |
NRC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 5 analist
AL
Medyan hedef
$26.00
+27,8%
1 20,0%
Güçlü Al
3 60,0%
Al
1 20,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-09-27Ortalama hedef $26.00 +27,8%
Düşük$26.00
Ortalama$26.00
Yüksek$26.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Son Haberler Bu şirketten bahseden son manşetler
US Nuclear Regulator Seeks Simpler Environmental Reviews To Boost Nuclear Expansion
ZeroHedge · 2 ay, 3 hafta önce
Onlarca Yıl İçin Satın Alınacak ve Tutulacak En İyi Nükleer Enerji Hisseleri
Nasdaq · 4 ay önce
10 Yıl Sonra NuScale Power Hissesi Almadığınıza Pişman Olacak Mısınız?
Nasdaq · 4 ay, 3 hafta önce
Oklo ve NuScale Power: İkisi de 2026'da Düşüyor, Ancak Şu Anda Sadece Biri Satın Almaya Değer
Nasdaq · 5 ay önce
New Jersey Valisi Sherrill, 40 Yıllık Nükleer Moratoryumu Kaldırıyor
ZeroHedge · 5 ay, 3 hafta önce
Bu Milyoner Olma Biletiniz Olabilir: Bu 10 Dolarlık Nükleer Enerji Hissesi
Nasdaq · 5 ay, 3 hafta önce
NuScale Power %80 düştü -- Bu Uzun Vadeli Yatırımcılar için Harika Bir Haber
Nasdaq · 6 ay önce
"Belirleyici Bir An": Nano Nuclear, Illinois'taki Kronos Reaktörü İçin İnşaat İzni Başvurusunda Bulundu
ZeroHedge · 6 ay önce
Oklo Sadece Bir NRC Lisansı Aldı. OKLO Hisselerini Bu Seviyeden Almalı mısınız?
Yahoo Finance · 6 ay, 2 hafta önce
"Önemli İzotoplara Yönelik Talep Artıyor, Tedarik Sınırlı": Oklo İlk NRC Lisansını ve Bir DOE Aşaması Daha Elde Etti
ZeroHedge · 6 ay, 2 hafta önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026